Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Experimental group:TCM+Routine treatment of Western Medicine
Sponsors
Tongde Hospital of Zhejiang Province
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: (1) Patients in accordance with the diagnostic criteria of "Quick reference guide for diagnosis and treatment of novel coronavirus pneumonia(2019-nCoV)(Standard Edition)" and "Diagnostic and treatment protocols of novel coronavirus pneumonia(Trial version 5)" issued by National Health Commission; (2) Patients in accordance with the TCM syndrome differentiation standard; (3) Aged 18 to 85 years; (4) Before the trial begins, patients or their legal representatives voluntarily agree to participate by giving written informed consent approved by ethic committee.
Exclusion criteria
Exclusion criteria: (1) Diagnosed with other known viral pneumonia,like influenza virus, parainfluenza virus, adenovirus, respiratory syncytical virus, rhinovirus, human metapneumovirus and SARS coronavirus, etc.; (2) Diagnosed with mycoplasma pneumonia, chlamydial pneumonia and bacterial pneumonia; (3) Diagnosed with vasculitis, dermatomyositis, organizing pneumonia and other noninfectious diseases; (4) pregnant or breastfeeding woman; (5) Known to be allergic to this medicine ingredient; (6) Patients with serious underlying disease, and researchers considered inappropriate to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body temperature;TCM syndrome integral;Murray lung injury score;The transition time of novel coronavirus nucleic acid;MuLBSTA score; | — |
Countries
China
Contacts
Public ContactKequn Chai
Tongde Hospital of Zhejiang Province
Outcome results
None listed